Geeze if i were a broker and hadn't heard of RFN I think someone would need to give me a slap across the face lol. CHP/CMY certainly agree there but
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%